Successful treatment of psoriatic nails with low-dose cyclosporine administration [5]

European Journal of Dermatology

Volumn 17, Issue 3, 2007, Pages 248-249

  Syuto, Tomoko ^a   Abe, Masatoshi ^a   Ishibuchi, Hirohisa ^a   Ishikawa, Osamu ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; RETINOID;

ADULT; AGED; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DRUG DOSE REDUCTION; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; LETTER; LOW DRUG DOSE; MALE; NAIL DISEASE; PATIENT SATISFACTION; PSORIASIS; PUVA; RELAPSE; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; CYCLOSPORINE; FEMALE; HUMANS; MALE; MIDDLE AGED; NAILS; PSORIASIS; TREATMENT OUTCOME;

EID: 34249776917     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. de Jong EMGJ, Seegers BAMPA, Gulinck MK, et al. Psoriasis of the nails associated with disability in a large number of patients: Results of a recent interview with 1,728 patients. Dermatology 1996; 193: 300-3
2. S. Cassell, A.F. Kavanaugh. Therapies for psoriatic nail disease. A systematic review. J Rheumatol 2006; 33: 1452-6
3. Piérard GE, Piérard-Franchimont C. Dynamics of psoriatic trachyonychia during low-dose cyclosporine A treatment: A pilot study on onychochronobiology using optical profilometry. Dermatology 1996; 192: 116-9
4. Mahrle G, Schulze HJ, Färber L, et al. Low-dose short-term cyclosporine versus etretinate in psoriasis: Improvement of skin, nail, and joint involvement. J Am Acad Dermatol 1995; 32: 78-88
5. Feliciani C, Zampetti A, Forleo P, et al. Nail psoriasis: Combined therapy with systemic cyclosporine and topical calcipotriol. J Cutan Med Surg 2004; 8(2): 122-5
6. Arnold WP, Gerritsen MJP, van de Kerkhof PCM. Response of nail psoriasis to cyclosporine. Br J Dermatol 1993; 129: 750-1